Elevian raises $15M in preclinical work towards clinical antiaging
FierceBiotech - 24-Nov-2020rGDF11 in clinic targets multiple age related disease therapies
Join the club for FREE to access the whole archive and other member benefits.
Investor, entrepreneurial community builder, advocate
Suzanne is a General Partner with Prime Movers Lab and now board member of Elevian investing in breakthrough scientific startups in energy, transportation, infrastructure, manufacturing, human augmentation and the future of computing.
She has 20 years of experience working in the technology and investment space.
Most recently, she spent five years at StartX, the Stanford University focused entrepreneur community, managing the Stanford-StartX Fund and working directly with hundreds of entrepreneurs.
Prior to that, she spent ten years doing secondary private equity investing. Suzanne started her career at Morgan Stanley in the Technology Financial Sponsors Group.
She earned an MBA from Stanford University and a BS in Finance and Information Systems from the Wharton School at the University of Pennsylvania magna cum laude.
Visit website: https://www.elevian.com/suzanne-fletcher
See also: Elevian - Young blood medicine maker for body rejuvenation.
Details last updated 25-Nov-2020
rGDF11 in clinic targets multiple age related disease therapies